KeynoteEsophageal

Explore an Investigational Immunotherapy Trial for Esophageal Cancers

As the sponsor of the Keynote Oncology Clinical Trials, Merck is passionate about improving health. We are committed to accelerating every step in the journey in our quest to bring treatment options to people with cancer.

Pembrolizumab has been FDA-approved for use in certain types of cancer.

To see if your patients qualify for one of these trials, contact our clinical trial information center at 1-888-577-8839. If you are interested in partnering with us as an investigator, call 1-800-290-4339.

3

Active Trials

1

Trials Recruiting

11

US Trial Locations